Work

A phase I trial of SR271425 given as a one hour infusion every 3 weeks to patients with advanced solid tumors

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.2030

Authors: S. Wadler, E. Loh, M. J. Pilat, L. Malburg, S. Holloway, N. Matthews, G. Shackleton, M. Valdivieso, P. Lorusso

Institutions: Cornell University, The Barbara Ann Karmanos Cancer Institute, Weill Cornell Medicine

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2591539300

Cites:

Cited by: 5

Related to: 10